Available Until 12/12/2023

Geriatric Pharmacy Clinical Sessions (Cert # L229377)

ACPE Numbers: Various – see listing below
Pre-Sale Date: N/A
Content Release Date: 12/14/2022
Expiration Date: 12/12/2023
Activity Type: Application-based
CE Credits: 5.0 (BPS and ACPE) contact hours
Activity Fee: $150 (ASHP member); $250 (non-member)

Activity Overview

The Clinical Sessions Package is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). Using a case-based approach, the activities provide high-level, interactive discussions on contemporary and emerging issues in geriatric pharmacy. 

The Geriatric Pharmacy Clinical Sessions Recertification Package consists of 4 activities (see table below) and provides up to 5.0 contact hours of continuing pharmacy education and/or recertification credit.   

These activities are part of the ASHP and ACCP professional development program for BCGP recertification approved by the BPS.  For pharmacists who maintain more than one certification, three of the activities are approved for multiple specialties (see table below).

These activities were presented as part of the 2022 Midyear Clinical Meeting and 2022 ACCP Annual Meeting. Learners who claimed ACPE credit for these activities as part of that meeting, should not claim ACPE credit again.

The American Society of Health-System Pharmacists and the American College of Clinical Pharmacy are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

These recertification activities are intended for board certified pharmacists seeking to update their knowledge and skills in:

  • Polypharmacy
  • Pharmacologic therapies
  • Alzheimer’s and Parkinson’s
  • Managing sleep

Board certified pharmacists are eligible to receive up to 5.0 contact hours of recertification credit for completing this package. To earn recertification credit, learners must review the activity content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment. 

Recertification credit is earned in the calendar year in which you pass the recertification assessment.

Learning Activity

ACPE Number

Contact Hours (ACPE & BPS)

Recertification Assessment

Watch Your Step! Navigating Polypharmacy to Minimize Fall Risk (BCGP)




Anything ARNI Can Do, SGLT2i Can Do Better? Debate of Pharmacologic Therapies in HFpEF (BCACP, BCGP)




Breaking Down Neurodegenerative Diseases: Pharmacy Updates in Managing Alzheimer’s and Parkinson’s (BCACP, BCGP)

0204-9999-22-287-H01-P 1.5 ACPE/BPS


Sweet Dream or Nightmare: Managing Sleep Complaints in Older Adults (BCACP, BCGP)




Watch Your Step! Navigating Polypharmacy to Minimize Fall Risk
ACPE #: 0204-9999-22-302-H01-P

  • Using the CDC STEADI algorithm, develop a falls prevention process that incorporates pharmacists.
  • Based on a review of the literature, assess medications with an increased fall risk in older adults.
  • Recommend medication strategies to decrease falls in older adults.

This activity is approved for Board Certified Geriatric Pharmacist (BCGP) recertification credit.

Anything ARNI Can Do, SGLT2i Can Do Better? Debate of Pharmacologic Therapies in HFpEF
ACPE #: 0204-9999-22-331-H01-P

  • Describe how historical heart failure therapies have failed to meet the needs of patients with HFpEF.
  • Evaluate the evidence for mineralocorticoid receptor antagonists, angiotensin receptor-neprilysin inhibitors, and sodium-glucose cotransporter 2 inhibitors in patients with heart failure with preserved ejection fraction.
  • Analyze common scenarios where newer therapies may be able to provide clinical benefit to patients with HFpEF.
  • Recommend a therapeutic plan for the management of a patient with heart failure with preserved ejection fraction using patient-specific factors.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Geriatric Pharmacist (BCGP) recertification credit.

Breaking Down Neurodegenerative Diseases: Pharmacy Updates in Managing Alzheimer’s and Parkinson’s
ACPE #: 0204-9999-22-287-H01-P

  • Explain the mechanisms of anti-amyloid antibodies on the breakthrough therapy pathway.
  • Evaluate anti-amyloid antibody treatment criteria, including strategies to mitigate and monitor for CNS adverse events in eligible patients.
  • Assess implications of anti-amyloid immunotherapy approval and potential barriers to routine use.
  • Develop an individualized treatment plan to optimize motor symptoms of PD utilizing novel therapies.
  • Evaluate the use of medications for the treatment of non-motor symptoms of PD.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Geriatric Pharmacist (BCGP) recertification credit.

Sweet Dream or Nightmare: Managing Sleep Complaints in Older Adults
ACPE #: 0217-9999-22-068-H01-P

  • Assess common sleep disorders in an older adult patient population.
  • Apply evidence regarding the safety and efficacy of pharmacotherapy when used to treat common sleep disorders.
  • Identify and manage complicating factors encountered in the management of sleep complaints in older adult patients.
  • Design a treatment regimen addressing common sleep complaints in older adults.
  • Identify areas in which a clinical pharmacist can improve patient outcomes regarding sleep disorder management.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Geriatric Pharmacist (BCGP) recertification credit.

Faculty bios

Danielle Fixen, PharmD, BCGP
Associate Professor
University of Colorado Skaggs School of Pharmacy
Denver, Colorado

Stormi E. Gale, PharmD, BCCP
Clinical Pharmacist/Cardiology Subject Matter Expert
Novant Health Matthews Medical Center
Baltimore, Maryland

Alina Kukin, PharmD, BCCP 
Cardiology Clinical Pharmacy Specialist
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania

Jenelle H. Montgomery, PharmD, BCACP, CPP 
Clinical Pharmacist
Duke University Hospital
Durham, North Carolina

Laura A. Schalliol, PharmD, BCACP, BCGP 
Associate Professor of Pharmacy Practice
South College School of Pharmacy
Knoxville, Tennessee

Kristin M. Zimmerman, PharmD, BCACP, BCGP
Associate Professor
Virginia Commonwealth University School of Pharmacy
Maidens, Virginia

Kimberly Zitko, PharmD, BCACP, BCGP
Assistant Professor of Pharmacy Practice
South College
Knoxville, Tennessee

Amie Blaszczyk, PharmD, BCGP, BCPS, FASCP*
Holly L. Byrnes, PharmD, BCPS
Rebecca Cope, PharmD, MPH, BCACP*
Dana G. Carroll, PharmD*
Susan R. Dombrowski, MS, RPh
Michelle L. Hilaire, PharmD, FCCP, BCPS, BCACP, CDE*
Kristi Hofer, PharmD
Nicholas Leon, PharmD, BCACP, BCPS, FCPP*
Lindsay M. Saum, PharmD, BCPS, BCGP*
Maria Shin, PharmD, BCGP, BCPS* 

*Content Matter Experts

Amarachi Amechi, PharmD, BCACP
Akua  Asare-Addo, PharmD, MPH, BCGP, BCPS
Ramadas Balasubramanian, PharmD, PhD, BCGP, BCACP, FASCP
Julie Caler, PharmD, BCGP
Tina Caliendo, PharmD BCGP BCACP
Amanda Carter, PharmD, BCACP
Jiahui Chen, PharmD, BCACP, BCGP
Carrie Chou, PharmD, BCACP, CDCES
Christine Chou, PharmD, BCPS, BCGP
Angela Considine, PharmD, BCGP, CSP
Ashley Crowl, PharmD, BCACP
Christin Davis, PharmD, BCACP, BCGP
Andrea Donaldson, PharmD, BCPS, BCGP
Brian Doss, PharmD, BCGP
Bryan Feagan, PharmD, BCPS, BCACP
Cynthi Feucht, PharmD, BCPS, BCGP
Angela Fortkamp, PharmD, BCGS
Cheryl Gainey, PharmD, BCPS, BCGP
Christopher Green, PharmD, BCACP
Elizabeth Haftel, PharmD, MPH, CDCES, BCACP
Drew Harmon, PharmD, RPh, BCGP
Allyson Helms, PharmD, MS, HSPA, BCPS, BCACP
Kate Hentzen, PharmD, BCACP, BCGP
Gregory Hughes, PharmD, BCPS, BCGP
Elizabeth Ingari, PharmD, BCACP
Catherine Lea, BSPharm, BCACP
Matthew Maddox, PharmD, JD, BCACP, BCGP
Cody Moriearty, PharmD, BCACP
Briana Murray, PharmD, BCACP
Erica Neff, PharmD, BCACP
Columbus Nettles, PharmD, BCACP
Brianna Patacini, PharmD, BCACP, CDCES, MBA
Chris Paxos, PharmD, BCPP, BCPS, BCGP
Allison (Kirstie) Perry, PharmD, BCACP
Polina Plotkin, PharmD, BCACP, BCGP
Jocelyn Reynoso, PharmD, BCPS, BCGP
Brianna Rhodes, PharmD, BCACP
Bernadeane B.  Roth, BSPharm, PharmD, BCACP
Edward Rucki, BSRPh, BCGP
Jason Rusk, PharmD, BCGP
Jessica Ryan, PharmD, BCGP, AAHIVP
Lindsay Sampson, PharmD, BCPS, BCGP
Ashley Score, PharmD, MS, BCACP
Elizabeth Sebranek, PharmD, BCPS, BCGP
Eric  Set, PharmD, APh, BCGP
Carman Silver, BS, MS, PharmD, BCACP, CDCES
Amy Skiff, PharmD, BCACP
Kelly Small, PharmD, BCACP, PCGP
Alyssa Stewart, PharmD, BCACP, CSP, CPP
Anne Teichman, PharmD, BCACP
Elise Tharp, PharmD, MPA, TTS, BCACP
Audrey Umbreit, PharmD, BCACP
Agnes Vitarini, PharmD
Michele Walker, PharmD, BCGP
Emily Walsh, PharmD, BCACP
Emily Wetherholt, PharmD, BCACP
Erin Williams, PharmD, BCGP
Daniel Witham, PharmD, BCGP
Huette Wong, PharmD, BCPS
Anna Woods, PharmD, BCACP, CDCES
Christine Wu, PharmD, BCGP, BCPS
Fuwang Xu, PharmD, BCOP, BCGP

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content. 

All faculty and planners for ASHP and ACCP education activities are qualified and selected by ASHP and ACCP and required to disclose any relevant financial relationships with commercial interests. ASHP and ACCP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity. 

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.

Activities which can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations.  Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity. 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity. 

These activities were developed by ASHP and ACCP.